Getting better
Coming off OCD medication: what to know first
You're doing better, maybe for a while now, and there's a question you keep almost asking. Do I still need this? Some people do get to stop. The relapse research has real answers, and the safe version of this decision is planned with your prescriber rather than run alone.
Key takeaways
- Some people with obsessive-compulsive disorder (OCD) do come off medication and stay well. The decision is made with your prescriber, on a plan, never solo and never abruptly.
- Relapse after stopping SSRIs is described as high. In pooled trials, staying on roughly halved the risk of relapse.
- A recommendation quoted in the relapse research is to continue for at least one to two years after responding before revisiting the question.
- Per the International OCD Foundation (IOCDF), doing exposure and response prevention (ERP) can reduce the relapse risk that follows stopping an SSRI.
- If symptoms climb after stopping, that's information about a chronic condition, and going back on is a conversation worth having early.
Can I stop my OCD medication?
It's a fair question with a real answer. Some people with obsessive-compulsive disorder do come off SSRIs, with their prescriber, after a long stretch of stable improvement. Relapse after stopping is described as high, though, which is why this is a decision you plan in the appointment, never a solo experiment and never an abrupt one.
The question usually shows up when things are going well. The mornings are quieter, the compulsions have shrunk, and a thought starts visiting. Maybe I don't need this anymore. Maybe the quiet is just me now.
Wanting off is not some reckless impulse. People have reasons that deserve to be said plainly, side effects that never fully left, or the cost and the refill logistics, or wanting to know how much of the quiet is the medication and how much is you.
One fact carries most of this decision. Per the IOCDF's medication guide, OCD is a chronic condition, and SSRIs help while you take them; they don't appear to keep working years after treatment stops. So stopping isn't paperwork at the end of a finished course. It's a real change in treatment.
Which is why the decision runs through the one person who can plan it and watch what happens next, your prescriber. Not a forum thread, and not a gut call on a good week with a few quietly skipped doses.
There's a calendar answer too. In a 2012 review of the relapse evidence, the quoted recommendation is to stay on for at least one to two years after you've responded before revisiting the question. Better for a month? That's not the milestone here. Better for a year or two is closer.
And if you're earlier in the story, still weighing whether to start or what a fair trial even looks like, that's its own ground, covered in what SSRIs actually do in OCD.
What happens when people stop?
In trials that followed people whose obsessive-compulsive disorder had improved on an SSRI, staying on the medication roughly halved the risk of relapse compared with stopping. A 2025 pooled analysis puts it concretely, about one relapse prevented for every five people who continued. High risk isn't certainty, and some people who stop stay well.
Start where your prescriber probably starts. The IOCDF's medication guide says it in one sentence: "The relapse rate of those patients who discontinue SSRI treatment is high and, as such, long-term treatment is commonly recommended."
"High" is doing a lot of work in that sentence, so it's worth looking at the trials behind it. The design is simple enough. Take people whose OCD has improved on a medication, keep some of them on it, switch the rest to a look-alike pill with nothing in it, tell nobody which is which, and watch.
One trial, reported in that same 2012 review, ran exactly this with escitalopram, an SSRI. Roughly half of the switched group relapsed. Among the people who stayed on, it was roughly a quarter, and the switched group relapsed sooner.
Zoom out and the pattern holds. A 2025 analysis pooled nine trials built this way, 1,084 people in all, and found that staying on roughly halved the risk of relapse. Put the other way around, for about every five people who stayed on rather than stopped, one relapse was prevented.
Both halves of that picture are worth holding at once. The medication you're thinking of leaving is doing live work right now, even on the days it's easy to forget you take it. And stopping isn't a sentence either. In the escitalopram trial, roughly half the people who came off hadn't relapsed by the study's end.
What no trial can tell you is which group you'd be in. The numbers set the stakes. They don't make the call for you.
What makes stopping safer?
Mostly three things. Time, meaning at least one to two years of good response before revisiting the question, per a recommendation quoted in the relapse-prevention research. Skills, because per the IOCDF, doing exposure and response prevention can reduce the relapse risk that follows stopping an SSRI. And a plan made with your prescriber, gradual and watched, with a way back agreed in advance.
The strongest card in your hand isn't a pill fact at all. The IOCDF's guide makes the point directly: "For some patients, engaging in exposure and response prevention (ERP) therapy can mitigate the risk of relapse that can follow discontinuation of an SSRI."
It makes sense when you line up what each treatment leaves behind. The medication helps at the level you take it, for as long as you take it. ERP is practice, learning on purpose that you can sit with the alarm without handing it a compulsion, and what you've practiced doesn't leave when the dose does. It's the part of all this I'd have you take seriously even if you never change a milligram.
Keep the guide's own hedge, though. "For some patients." Skills shift the odds, and nobody serious promises more than that.
Time is the second factor. The one-to-two-year recommendation means the question gets asked from a long stretch of banked stability rather than from one good month.
The third factor is the exit itself. With your prescriber it's gradual and watched. How fast, and in what steps, gets worked out for your case and adjusted as you go. Timing belongs in that conversation too, like what the next few months are asking of you and whether now is a reasonable time to run this change. None of it is a kit you assemble alone.
And plan for the honest possibility while you're at it. If the volume starts climbing after you stop, that's information about a chronic condition, not a verdict on you. It also comes with options, and going back on is one of them. Agree in advance on what you'd both watch for and what you'd do about it, so a hard month gets met with a plan instead of a scramble.
How do I talk to my prescriber about it?
Directly, and sooner than feels natural. Say the actual sentence. I want to talk about coming off my OCD medication. A good prescriber treats that as a planning conversation, not a confession you owe anyone. Bring how long you've been stable, what the medication costs you in side effects, what's ahead in your life, and whether you've done ERP.
There's a version of this conversation that never happens. You mean to raise it, the appointment runs short, and you leave with a refill and the question still in your pocket. I think plenty of people carry it that way for a year.
There's also a version that happens without the prescriber. Maybe part of you has drafted it already. I'll just skip a few doses and see how I feel. That urge belongs in the room, said out loud, because an unplanned stop is the same decision with the safety rails taken off. Nobody watching, and no agreed picture of what would count as trouble. The National Institute of Mental Health (NIMH) OCD brochure keeps the rule to one line. Don't stop your medication without first talking to your health care provider.
Then make the case the way you'd make any medical case. Worth bringing:
- The calendar. How long you've felt steady, in your own words.
- The costs. Side effects, money, how you feel about taking a pill at all.
- What's ahead. The next few months matter, because you're picking the ground this change stands on.
- The skills. Whether you've done ERP, and whether doing it first belongs in the plan.
Side effects deserve their own airtime. The 2025 pooled analysis put its conclusion carefully: "Individuals with OCD may benefit from continued antidepressant treatment, provided that it is well tolerated." That last clause is the researchers saying your costs count. If the quiet comes at a price you hate, say the price out loud, because it's data your prescriber needs.
Expect a conversation with more than two endings. Maybe you build the exit plan together. Maybe the answer is not yet, with a reason attached and a date to revisit. Maybe it's ERP first, then the question again in a few months. Any of those is the decision working the way it should, with somebody watching who knows how to plan.
One thing is worth doing before the appointment. Get the long view. Medication is one thread of what recovery from OCD actually looks like, dips included, and this question gets easier once you've seen the whole picture. You're reading about it on a steady day, which is exactly the right day to plan. Book the appointment. Say the sentence.
Common questions
How long should I stay on OCD medication?
Will my OCD come back if I stop medication?
Can I stop medication if I did ERP?
Sources
- Poskar S. Medication Treatment for Obsessive Compulsive Disorder in Adults. International OCD Foundation. iocdf.org/about-ocd/ocd-treatment-guide/medication
- Kishi T, Sakuma K, Hatano M, Hamanaka S, Nishii Y, Iwata N. Relapse rates in stable obsessive-compulsive disorder after antidepressant discontinuation versus maintenance: a systematic review and meta-analysis. Psychol Med, 2025. pubmed.ncbi.nlm.nih.gov/40874319
- Fineberg NA, et al. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol, 2012;15(8):1173-1191. academic.oup.com/ijnp/article/15/8/1173
- National Institute of Mental Health. Obsessive-Compulsive Disorder: When Unwanted Thoughts or Repetitive Behaviors Take Over. nimh.nih.gov (brochure) www.nimh.nih.gov/health/publications/obsessive-compulsive-disorder-when-unwanted-thoughts-or-repetitive-behaviors-take-over
Skills that stay when doses change
Conicia is a step-by-step program for understanding OCD and building skills for daily life, from a psychiatrist who has focused on treating OCD for over a decade. Use it on your own, or alongside the care you already have.
For adults 18 and over. Your account is free to create, and your first two lessons and three relief tools are free to use.